201 related articles for article (PubMed ID: 8213543)
1. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.
Kornowski R; Goldbourt U; Zion M; Mandelzweig L; Kaplinsky E; Levo Y; Behar S
Am J Cardiol; 1993 Oct; 72(12):883-8. PubMed ID: 8213543
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of reinfarction among men and women after a first myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Kornowski R; Goldbourt U; Boyko V; Behar S
Cardiology; 1995; 86(2):163-8. PubMed ID: 7728808
[TBL] [Abstract][Full Text] [Related]
3. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
Haim M; Hod H; Reisin L; Kornowski R; Reicher-Reiss H; Goldbourt U; Boyko V; Behar S
Am J Cardiol; 1997 Mar; 79(6):717-21. PubMed ID: 9070547
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
[TBL] [Abstract][Full Text] [Related]
5. Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
Behar S; Rabinowitz B; Zion M; Reicher-Reiss H; Kaplinsky E; Abinader E; Agmon J; Friedman Y; Kishon Y; Palant A
Am J Cardiol; 1993 Dec; 72(18):1366-70. PubMed ID: 8256728
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Benderly M; Behar S; Reicher-Reiss H; Boyko V; Goldbourt U
Am J Epidemiol; 1997 Jul; 146(2):153-60. PubMed ID: 9230777
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine Trial.
Kornowski R; Goldbourt U; Reicher-Reiss H; Reisin L; Haim M; Moshkovitz Y; Caspi A; Behar S
Cardiology; 1997; 88(5):441-5. PubMed ID: 9286506
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
[TBL] [Abstract][Full Text] [Related]
10. Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial).
Birnbaum Y; Kloner RA; Sclarovsky S; Cannon CP; McCabe CH; Davis VG; Zaret BL; Wackers FJ; Braunwald E
Am J Cardiol; 1996 Aug; 78(4):396-403. PubMed ID: 8752182
[TBL] [Abstract][Full Text] [Related]
11. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia.
Welty FK; Mittleman MA; Lewis SM; Healy RW; Shubrooks SJ; Muller JE
Am J Cardiol; 1995 Sep; 76(7):431-5. PubMed ID: 7653439
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction.
Jespersen CM
Clin Cardiol; 1997 Jul; 20(7):623-6. PubMed ID: 9220178
[TBL] [Abstract][Full Text] [Related]
13. Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus.
Arnold SV; Spertus JA; Jones PG; McGuire DK; Lipska KJ; Xu Y; Stolker JM; Goyal A; Kosiborod M
Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):372-9. PubMed ID: 27220369
[TBL] [Abstract][Full Text] [Related]
14. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study.
Berger CJ; Murabito JM; Evans JC; Anderson KM; Levy D
JAMA; 1992 Sep 23-30; 268(12):1545-51. PubMed ID: 1518109
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis after a first myocardial infarction in Turkey: determinants of mortality and reinfarction.
Yüksel H; Güzelsoy D; Yazicioğlu N; Senocak M; Oztürk M; Demiroğlu C
Cardiology; 1994; 84(4-5):345-55. PubMed ID: 8187123
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of clinical variables for recurrent ischemic events after acute myocardial infarction.
Piombo AC; Gagliardi JA; Ulmete ER; Ramos AO; Bertolasi CA
Clin Cardiol; 1995 Mar; 18(3):157-60. PubMed ID: 7743687
[TBL] [Abstract][Full Text] [Related]
17. Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction (the GISSI-3 APPI [angina precoce post-infarto] study).
GISSI-3 APPI Study Group
Am J Cardiol; 1996 Dec; 78(11):1191-7. PubMed ID: 8960573
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of angina pectoris prior to acute myocardial infarction and its relation to prognosis.
Herlitz J; Karlson BW; Richter A; Liljeqvist JA; Wiklund O; Hjalmarson A
Eur Heart J; 1993 Apr; 14(4):484-91. PubMed ID: 8472711
[TBL] [Abstract][Full Text] [Related]
19. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences in mortality of male and female patients surviving acute myocardial infarction: long-term follow-up of 5,700 patients. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
Harpaz D
Eur J Epidemiol; 1997 Oct; 13(7):745-54. PubMed ID: 9384262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
